Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
85 hedge funds and large institutions have $109M invested in Calithera Biosciences, Inc in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 20 closing their positions.
81% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 21
8% less funds holding
Funds holding: 92 → 85 (-7)
18% less capital invested
Capital invested by funds: $134M → $109M (-$24.5M)
35% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 20
42% less call options, than puts
Call options by funds: $127K | Put options by funds: $218K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$5.8M |
| 2 |
BlackRock
New York
|
+$3.57M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$1.74M |
| 4 |
Renaissance Technologies
New York
|
+$1.32M |
| 5 |
JP Morgan Chase
New York
|
+$873K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$3.29M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.95M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.92M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.17M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$758K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DTL
101
Dynamic Technology Lab
Singapore
| – | -$66K | -840 | Closed |
|
102
Ohio Public Employees Retirement System (OPERS)
Columbus,
Ohio
| – | -$21K | -271 | Closed |
|
103
Group One Trading
Chicago,
Illinois
| – | -$17K | -212 | Closed |
|
|
PHK
104
Point72 Hong Kong
Hong Kong
| – | -$6K | -77 | Closed |
|
105
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$4K | -55 | Closed |
|
CALA Hedge Fund Activity: Q3 2019 in Review
85 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2019, worth a combined $109M — down 18% from $134M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of CALA and 13 opened new positions — a net loss of 7 holders — while 21 trimmed existing stakes and 38 added.
The largest buyer was Federated Hermes, adding an estimated $5.8M. The largest seller was CVI Holdings, exiting entirely with an estimated $3.29M sold.
- 85 institutional investors held Calithera Biosciences, Inc (CALA) as of Q3 2019, down from 92 in Q2 2019.
- Funds reported $109M of Calithera Biosciences, Inc stock for Q3 2019, down 18% quarter-over-quarter.
- 13 funds opened new Calithera Biosciences, Inc positions in Q3 2019 and 20 closed out, a net change of -7 holders.
- The largest Calithera Biosciences, Inc buyer in Q3 2019 was Federated Hermes, an estimated $5.8M added.
- The largest Calithera Biosciences, Inc seller in Q3 2019 was CVI Holdings, an estimated $3.29M sold.
Based on aggregated 13F filings for Q3 2019.